Russia and China to build a new pharmaceutical plant in the Irkutsk region
A Russian pharmaceutical company and its Chinese partner have announced the launch of a joint project. The parties have agreed to build a new plant for the production of pharmaceutical substances, which will be located in the Irkutsk region.
The total cost of the project is estimated at 13.06 billion tenge. The investments will be directed toward creating modern production lines and purchasing the necessary equipment. It is expected that the new facility will significantly increase the domestic production volume of medicinal components.
Cooperation with Chinese specialists will help introduce advanced technologies into the production process. This is an important step for the development of the Russian pharmaceutical industry, as the creation of domestic substances reduces dependence on imported raw materials.
The construction of the plant will also create new jobs for residents of the region. The project is planned to be implemented in the coming years, which should have a positive impact on the availability of high-quality medicines for Russian patients.